Skip to content

Busamed Modderfontein Oncology Centre

The Busamed Modderfontein Oncology Centre, situated in the heart of Modderfontein is housed in the Busamed Modderfontein Private Hospital in Linbro Park.

Treatments Provided:

Adult & Paediatric
  • Radiation treatment
  • Cobalt – 60 flexitron Brachytherapy
  • Stereotactic Radiosurgery

The aim is to achieve cure, long term control or palliation in a caring friendly environment.
The centre is managed by a team of leading radiation oncologists, radiation therapists and medical physicists.

For more Information contact:

Lindiwe Fokazi – Oncology Manager
Tel: +27 11 458 2089

4 Cransley Crescent,
(On Marlboro Drive),
Long Lake, Ext 12, Linbro Park, 2090



The Varian Unique linear accelerator utilises advanced technology in the treatment of various types of cancers. This new generation tool provides even greater speed and accuracy with an electronic portal imaging system used for verification of a patient’s position.

This state of the art linear accelerator is capable of delivering 3D, IMRT, VMAT treatment to the tumour with precision, destroying the cancer whilst sparing the surrounding normal tissues. This results in less short and long term side effects, usually experienced by the patients who undergo radiation therapy.


Planning System

Busamed Modderfontein Oncology has a state of the art planning system (latest version) which delivers speed in dose calculation, thereby reducing the planning time required.


Chemotherapy Unit

The centre has a chemotherapy facility which enables the patient to receive concurrent oncology care on the same premises. An experienced pharmacist will be available at all times as well as a highly oncology nursing sister with extensive experience in the field.


Flexitron Brachytherapy Machine

This remarkable remote after loader platform offers simple, intuitive brachytherapy which provides an optimised treatment delivery process. With its multi-channel option, we are able to treat all kinds of cancers including gynaecological cancers, oesophagus, interstitial, nasopharynx and other cancers.

Due to its targeted nature, side effects are minimised and treatment times are reduced.